StemRIM Inc.
Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.
4599 | T
Overview
Corporate Details
- ISIN(s):
- JP3399690001
- LEI:
- Country:
- Japan
- Address:
- 茨木市彩都あさぎ７丁目７番１５号
- Website:
- https://stemrim.com/english/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
StemRIM Inc. is a biotechnology company engaged in the research and development of a next-generation class of regenerative medicine called "Regeneration-Inducing Medicine™". Originating as a venture from Osaka University, the company focuses on developing drugs with a novel mechanism of action. This approach aims to maximize the body's innate ability to repair itself by recruiting a patient's own in-vivo stem cells to damaged tissues, thereby inducing functional regeneration without conventional cell-therapy. The company's drug development pipelines target intractable diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-12 06:38 |
Registration Form
有価証券届出書（参照方式）
|
Japanese | 49.2 KB | ||
| 2025-10-21 08:10 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2025-10-21 08:10 |
Annual Report
有価証券報告書－第20期(2024/08/01－2025/07/31)
|
Japanese | 2.7 MB | ||
| 2025-09-12 05:32 |
Share Issue/Capital Change
訂正臨時報告書
|
Japanese | 30.7 KB | ||
| 2025-03-13 04:31 |
Report Publication Announcement
確認書
|
Japanese | 8.0 KB | ||
| 2025-03-13 04:30 |
Interim Report
半期報告書－第20期(2024/08/01－2025/07/31)
|
Japanese | 228.6 KB | ||
| 2024-11-25 08:13 |
Registration Form
有価証券届出書（参照方式）
|
Japanese | 49.5 KB | ||
| 2024-11-18 01:31 |
Share Issue/Capital Change
訂正臨時報告書
|
Japanese | 32.6 KB | ||
| 2024-11-13 08:10 |
Regulatory News Service
臨時報告書
|
Japanese | 36.2 KB | ||
| 2024-10-31 05:28 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 22.4 KB | ||
| 2024-10-31 03:35 |
Governance Information
内部統制報告書－第19期(2023/08/01－2024/07/31)
|
Japanese | 21.0 KB | ||
| 2024-10-31 03:35 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2024-10-31 03:32 |
Annual Report
有価証券報告書－第19期(2023/08/01－2024/07/31)
|
Japanese | 2.7 MB | ||
| 2024-07-26 08:53 |
Regulatory News Service
臨時報告書
|
Japanese | 35.7 KB | ||
| 2024-07-26 08:53 |
Regulatory News Service
臨時報告書
|
Japanese | 35.8 KB |
Automate Your Workflow. Get a real-time feed of all StemRIM Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for StemRIM Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for StemRIM Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
